Age-Related KLHL22 Expression in Human MSCs and Regenerative Implications
Author:
Utley JamesORCID, Briggs DanielORCID
Abstract
AbstractAging in human bone marrow-derived mesenchymal stromal cells (hMSCs) affects their regenerative capabilities and therapeutic efficacy, which are critical for successful cell-based regeneration therapies. In this study, we aimed to identify genetic markers of aging in hMSCs to better understand the impact of donor age on cell function. We conducted analysis on data from genome-wide microarray analysis on early-passage hMSCs isolated from the bone marrow of 61 donors aged between 17 and 84 years found in the GSE39540 public dataset. One such gene, identified asKLHL22 (ENSG00000099910), showed a significant negative correlation with age (p=0.032), with a regression slope of −0.0089 indicating decreased expression in older donors. TheR2R2 value of 0.243 suggests that approximately 24.3% of the expression variability of this gene can be explained by age. These findings are consistent with the known decline in tissue maintenance and regeneration capabilities in aging hMSCs and may reflect broader aging processes impacting cell-based therapies. Our results provide insight into the molecular basis of aging in hMSCs and highlight the potential of using gene expression profiles as markers to select more potent hMSCs for therapeutic applications. This gene signature could serve as a foundation for developing strategies to rejuvenate aged hMSCs, enhancing the efficacy of regenerative therapies.
Publisher
Cold Spring Harbor Laboratory
Reference6 articles.
1. Gao, C. (2023). Design and Screening of KLHL22 Inhibitors by Homology Modeling, Molecular Docking, and Molecular Dynamics Simulation. Letters in Drug Design & Discovery. 2. A Mesenchymal Stromal Cell Gene Signature for Donor Age 3. Peng, F. , Zhou, L. , Lu, W.-J. , Gan, R.-H. , Lu, M. , Li, Z. , Zhang, X.-J. , Wang, Y. , & Gui, J. (2023). Genomic and Transcriptional Profiles of Kelch-like (klhl) Gene Family in Polyploid Carassius Complex. International Journal of Molecular Sciences. 4. Liu, X. , Wang, W. , & Li, H. (2020). KLHL22 promotes malignant melanoma growth in vitro and in vivo by activating the PI3K/Akt/mTOR signaling pathway. Neoplasma. 5. Zhou, X. A. , Zhou, J. , Zhao, L. , Yu, G. , Zhan, J. , Shi, C. , Yuan, R. , Wang, Y. , Chen, C. , Zhang, W. , Xu, D. , Ye, Y. , Wang, W. , Shen, Z. , Wang, W. , & Wang, J. (2020). KLHL22 maintains PD-1 homeostasis and prevents excessive T cell suppression. Proceedings of the National Academy of Sciences of the United States of America.
|
|